Research and Markets: Access All the Important Information and Analysis on Sonus Pharmaceuticals Inc in a Single Report!

Business Wire, March 4, 2008

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c84772) has announced the addition of "Sonus Pharmaceuticals Inc: Premium Company Profile" to their offering.

Sonus Pharmaceuticals' main focus is to discover, develop and commercialize products for the treatment of diseases in the therapeutic area of oncology. The company seeks to build a franchise of oncology products through its own internal efforts.

Scope

- Contains corporate strategy, value chain presence and SWOT Analysis

- Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors

- Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights of this title

Sonus Pharmaceuticals is focused on the discovery, development and commercialization of pharmaceutical products for oncology indications. The company has only one program in its pipeline, namely, TOCOSOL Camptothecin, for the treatment of solid tumors.

Sonus derives its revenues from collaboration and licensing agreements. These revenues are related to the collaboration agreement with Bayer Schering, under which Bayer Schering was granted worldwide exclusive license to market and promote TOCOSOL Paclitaxel and was responsible for clinical development and regulatory activities outside of the US.

Sonus aims to apply its focus on advancing its second oncology product candidate, TOCOSOL Camptothecin, which was moved into a Phase I clinical trial in September 2006. In addition, it intends to identify and acquire products/technologies that are complementary to its focus in oncology in order to broaden the business and market opportunities.

Key reasons to purchase this title

- Access all the important information and analysis on the company in a single report

- Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain

- Gain access to companys adjusted five year financial data along with key ratios and market capitalization

For more information, visit http://www.researchandmarkets.com/reports/c84772.

Source: Datamonitor